Abstract | OBJECTIVE: CASE SUMMARY: DISCUSSION: CONCLUSIONS: As with all new and innovative drugs, thorough documentation of infrequent adverse events is necessary. We would like to raise awareness for ageusia, which appears to be a rare but severely impairing adverse reaction to a relatively new pharmacologic agent.
|
Authors | Philipp Kiewe, Sergije Jovanovic, Eckhard Thiel, Agnieszka Korfel |
Journal | The Annals of pharmacotherapy
(Ann Pharmacother)
2004 Jul-Aug
Vol. 38
Issue 7-8
Pg. 1212-4
ISSN: 1060-0280 [Print] United States |
PMID | 15161947
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Liposomes
- Polyethylene Glycols
- Doxorubicin
|
Topics |
- Aged
- Ageusia
(chemically induced)
- Antineoplastic Agents
(administration & dosage, adverse effects, chemistry)
- Doxorubicin
(administration & dosage, adverse effects, chemistry)
- Humans
- Liposomes
- Male
- Multiple Myeloma
(drug therapy)
- Polyethylene Glycols
(chemistry)
|